Hartford Financial Management’s Ginkgo Bioworks DNA Stock Holding History

Hartford Financial Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$645	Hold	65	–	–	﹤0.01%	342
2026 Q1	$399	Hold	65	–	–	﹤0.01%	336
2025 Q4	$541	Hold	65	–	–	﹤0.01%	328
2025 Q3	$948	Hold	65	–	–	﹤0.01%	328
2025 Q2	$732	Hold	65	–	–	﹤0.01%	338
2025 Q1	$371	Hold	65	–	–	﹤0.01%	353
2024 Q4	$639	Hold	65	–	–	﹤0.01%	370
2024 Q3	$530	Hold	65	–	–	﹤0.01%	374
2024 Q2	$870	Buy	+65	New	+$1.94K	﹤0.01%	376

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Hartford Financial Management's DNA Position: Q2 2026 in Review

Hartford Financial Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 65 shares worth $645. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Hartford Financial Management first reported a position in DNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $948 in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Hartford Financial Management held 65 shares of Ginkgo Bioworks worth $645 as of Q2 2026.
Hartford Financial Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Hartford Financial Management's portfolio in Q2 2026, its #342 holding.
Hartford Financial Management first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 9 quarters since.
Hartford Financial Management's Ginkgo Bioworks position peaked at $948 in Q3 2025.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.